Previous studies have demonstrated that the Ki-67 proliferation index is an accurate gage of prognosis in NSCLC, and that Ki-67 > 25% is associated with poor prognosis in stage I-IV pulmonary adenocarcinoma (14). This evidence concerns the gene MKI67 and non-small cell lung carcinoma.